Antibiotic resistance among gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia

Journal of Chemotherapy

Volumn 13, Issue 3, 2001, Pages 260-264

  El Tahawy, A T A E ^a   Khalaf, R M F ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Antibiotics; Gram negative non fermentative bacteria; Resistance patterns

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; TRIMETHOPRIM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; GRAM NEGATIVE BACTERIUM; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; SAUDI ARABIA; STENOTROPHOMONAS MALTOPHILIA; TEACHING HOSPITAL; WARD;

EID: 0034971910     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.3.260     Document Type: Article

References (41)

1. Nosocomial infection in the intensive care unit: A question of surveillance
2. Antimicrobial resistance in hospital organisms and its relation to antibiotic use
3. Hospital infection with Acinetobacter spp: An increasing problem
4. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical and epidemiological features
5. Endemic Acinetobacter strains in a surgical intensive care unit: Mechanical ventilators as reservoir
6. The increasing of outbreaks of Acinetobacter spp: The need for control and new agents
7. Emergence of isolates of Acinetobacter calcoaceticus - Acinetobacter baumannii complex in a Spanish hospital over a five-year period
8. Emergence of multidrug-resistant isolates of Acinetobacter baumannii
9. Infections caused by Pseudomonas maltophilia
10. Bacteremia caused by non-aeruginosa Pseudomonas species in a cancer centre
11. Infections in patients with acute leukaemia and lymphoma
12. Hospital infections caused by Pseudomonas aeruginosa: Significance of intensive therapy
13. Resistance in Pseudomonas aeruginosa: An Italian Survey
14. The changing epidemiology of severe infections in the ICU
15. «Bacterial Resistance» of the Paul Ehrlich Society for Chemotherapy. Prevalence of fluroquinolone resistance in Europe
16. The prevalence of nosocomial infection in intensive care units in Europe
17. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa
18. Transferable imipenem resistance in Pseudomonas aeruginosa
19. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
20. Nosocomial acquisition of multiresistant Acinetobacter baumannii: Risk factors and prognosis
21. Investigation of a multi-year multiple critical care outbreak due to relatively drug-sensitive Acinetobacter baumannii. Risk factors and attributable mortality
22. Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii
23. Bacteremia with Acinetobacter species: Risk factors and prognosis in different clinical settings
24. Acinetobacter bacteremia in HongKong: Prospective study and review
25. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period
26. Survey on antibiotic resistance in Gram-negative non-fermentative bacteria other than Pseudomonas in Italy
27. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: Results of the case-control and molecular epidemiologic investigations
28. Nosocomial respiratory tract colonization and infection with aminoglycoside resistant A. calcoaceticus var. anitratus: Epidemiologic characteristics and clinical significance
29. Distribution of beta-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus
30. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin binding proteins
31. Mechanisms of resistance to betalactam antibiotics in Acinetobacter calcoaceticus
32. Multiple antibiotic resistance in Pseudomonas aeruginosa: Evidence for involvement of an efflux operon
33. The emergence of epidemic, multiple antibiotic resistant Stenotrophomonas maltophilia and Burkholderia cepacia
34. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: Implication for therapy
35. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN 12873
36. Sensitivity of L2-type beta-lactamases from Stenotrophomonas maltophilia to serine active site beta-lactamase inhibitors
37. Biochemical properties of inducible beta-lactamase produced from Xanthomonas maltophilia
38. Microbiological and clinical aspects of infection associated with Stenotrophomans maltophilia
39. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management
40. Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia